MKI67 and metastatic malignant neoplasm in the lymph nodes: In previous literature, Ki-67-IHC has been observed as a predictive feature for pCR [40], whereas high Ki-67 labeling index in residual lymph node metastases may predispose to chemotherapy resistance [43].